Prevalencia del Diagnóstico Post-COVID-19 en el Centro Integral de Atención Provisional (FIGALI) durante el Primer Trimestre del 2021

[Prevalence of Post-COVID-19 Diagnosis in the Comprehensive Interim Care Center (FIGALI) during the First Quarter of 2021]

Diago Arcia Arcia De la Ossa1, Lyanne Gómez 2, Raúl Ng Fábrega3, Luis Felipe Velásquez González4

1. Complejo Hospitalario Dr. Arnulfo Arias Madrid,CSS, Panamá, Panamá; 2. Ministerio de Salud, Los Santos, Panamá; 3. Hospital Regional Rafael Hernández, David, Chiriquí, Panamá; 4. Ministerio de Salud de Panamá, San Miguelito, Panamá, Panamá.

Publicado: 2022-08-30

Descargas

Archivos adicionales

Resumen

Introducción: El Síndrome Post-COVID-19 ha sido la terminología mas acuñada para el diagnóstico de las secuelas que persisten por más de 3 meses posterior a la infección por el virus SARS-CoV-2. Objetivo: Determinar la prevalencia del Diagnóstico Post-COVID-19. Metodología: Estudio descriptivo, transversal, retrospectivo y observacional. El universo consiste en todos los pacientes mayores de edad hospitalizados que ameritaron oxigenoterapia en el Centro Integral de Atención Provisional para Pacientes Moderados COVID-19 (FIGALI) durante el primer trimestre de 2021. Se describen los datos demográficos, las comorbilidades, los principales síntomas persistentes y la asistencia a Clínicas Post-COVID.
Resultados: Predominaron los mayores a 50 años (66%), con una estadía promedio de 10 días, ameritando la mayoría (79%) oxigenoterapia de bajo flujo (COVID-19 moderado), con distribución equitativa del sexo y mayoría de los encuestados tenía un mínimo de 5 meses de egresados. Las principales comorbilidades reportados fueron la hipertensión arterial (57%) y la diabetes mellitus (31%). La prevalencia del Diagnóstico Post-COVID-19 fue de 74% (131/177), siendo la fatiga, la tos y la disnea los principales síntomas reportados (45%, 32%, 29%) respectivamente. En el aspecto neuro-psiquiátrico se evidencia la ansiedad con un 18% y la depresión en 14% de los pacientes encuestados. Conclusiones: tres de cada cuatro pacientes que ameritaron oxigenoterapia, han persistido con al menos 1 síntoma luego de más de 5 meses de haber estado hospitalizado, siendo la fatiga el predominante. A pesar de la alta prevalencia descrita en este estudio, tan solo uno de cada cuatro pacientes, reporta haber acudido a Clínicas Post-COVID.


Abstract

Introduction: Post-COVID-19 Syndrome has been the most coined terminology for the diagnosis of sequelae that persist for more than 3 months following SARS-CoV-2 virus infection. Objective: To determine the prevalence of post-COVID-19 diagnosis. Methodology: Descriptive, cross-sectional, retrospective, and observational study. The universe consists of all hospitalized patients of legal age who required oxygen therapy at the Centro Integral de Atención Provisional para Pacientes Moderados COVID-19 (FIGALI) during the first quarter of 2021. Demographic data, comorbidities, main persistent symptoms, and attendance to Post-COVID Clinics are described. Results: Predominantly those older than 50 years (66%), with an average stay of 10 days, most (79%) requiring low-flow oxygen therapy (moderate COVID-19), with equal distribution of sex and most respondents had a minimum of 5 months of discharge. The main comorbidities reported were hypertension (57%) and diabetes mellitus (31%). The prevalence of post-COVID-19 Diagnosis was 74% (131/177), with fatigue, cough and dyspnea being the main symptoms reported (45%, 32%, 29%) respectively. In the neuro-psychiatric aspect, anxiety was evident with 18% and depression in 14% of the patients surveyed. Conclusions: three out of four patients who required oxygen therapy persisted with at least one symptom more than 5 months after hospitalization, with fatigue being the predominant symptom. Despite the high prevalence described in this study, only one out of four patients reported having attended Post-COVID Clinics.

Citas

[1] R&d blue print. (2020). Gcm teleconference. In Pneumonia of unknown etiology in Wuhan, China – Note for the Records - 10 January 2020 (pp. 1-2). Teleconference; WHO. Retrieved 12 April 2022, from https://www.who.int/publications/m/item/gcm-teleconference-on-pneumonia-of-unknown-etiology-in-wuhan-china-note-for-the-records---10-january-2020.

[2] Mahmud, R., Rahman, M., Rassel, M., Monayem, F., Sayeed, S., Islam, M., & Islam, M. (2021). Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLOS ONE, 16(4), e0249644. https://doi.org/10.1371/journal.pone.0249644

[3] COVID-19 Map - Johns Hopkins Coronavirus Resource Center. Johns Hopkins Coronavirus Resource Center. (2022). Retrieved 16 June 2021, from https://coronavirus.jhu.edu/map.html.xxx[4] Halpin, S., McIvor, C., Whyatt, G., Adams, A., Harvey, O., & McLean, L. et al. (2020). Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation. Journal Of Medical Virology, 93(2), 1013-1022. https://doi.org/10.1002/jmv.26368

[4] Morin, L., Savale, L., Pham, T., Colle, R., Figueiredo, S., & Harrois, A. et al. (2021). Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. JAMA, 325(15), 1525. https://doi.org/10.1001/jama.2021.3331

[5] Fernández-de-las-Peñas, C., Palacios-Ceña, D., Gómez-Mayordomo, V., Cuadrado, M., & Florencio, L. (2021). Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. International Journal Of Environmental Research And Public Health, 18(5), 2621. https://doi.org/10.3390/ijerph18052621

[6] Raveendran, A., Jayadevan, R., & Sashidharan, S. (2021). Long COVID: An overview. Diabetes &Amp; Metabolic Syndrome: Clinical Research &Amp; Reviews, 15(3), 869-875. https://doi.org/10.1016/j.dsx.2021.04.007

[7] Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., Luo, J., Huang, Z., Tu, S., Zhao, Y., Chen, L., Xu, D., Li, Y., Li, C., Peng, L., Li, Y., … Cao, B. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London, England), 397(10270), 220–232. https://doi.org/10.1016/S0140-6736(20)32656-8

[8] Marshall, M. (2020). The lasting misery of coronavirus long-haulers. Nature, 585(7825), 339-341. https://doi.org/10.1038/d41586-020-02598-6

[9] Xiong, Q., Xu, M., Li, J., Liu, Y., Zhang, J., Xu, Y., & Dong, W. (2021). Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clinical Microbiology And Infection, 27(1), 89-95. https://doi.org/10.1016/j.cmi.2020.09.023

[10] Cares-Marambio, K., Montenegro-Jiménez, Y., Torres-Castro, R., Vera-Uribe, R., Torralba, Y., & Alsina-Restoy, X. et al. (2021). Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Chronic Respiratory Disease, 18, 147997312110022. https://doi.org/10.1177/14799731211002240

[11] Liyanage-Don, N., Cornelius, T., Sanchez, J., Trainor, A., Moise, N., Wainberg, M., & Kronish, I. (2021). Psychological Distress, Persistent Physical Symptoms, and Perceived Recovery After COVID-19 Illness. Journal Of General Internal Medicine, 36(8), 2525-2527. https://doi.org/10.1007/s11606-021-06855-w

[12] Martinez, L. (2020). Panamá inauguró primera clínica post-covid en América Latina. ECO NEWS, p. 1. Retrieved 18 July 2022, from https://www.ecotvpanama.com/programas/eco-news/panama-inauguro-primera-clinica-post-covid-en-america-latina_1_66130.

×